Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,414 | 45,640 | 61,943 | 68,016 | 75,180 |
| Marketable Securities | 37,724 | 43,279 | 12,700 | 32,391 | 55,986 |
| Receivables | 1,960 | N/A | N/A | N/A | N/A |
| Inventories | 5,340 | 1,983 | 3,312 | 2,744 | N/A |
| TOTAL | $62,143 | $93,974 | $81,130 | $108,201 | $134,751 |
| Non-Current Assets | |||||
| PPE Net | 5,076 | 4,702 | 4,471 | 3,645 | 3,049 |
| Other Non-Current Assets | 263 | 130 | 130 | 0 | 45 |
| TOTAL | $5,339 | $4,832 | $4,601 | $3,645 | $3,094 |
| Total Assets | $67,482 | $98,806 | $85,731 | $111,846 | $137,845 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,814 | 6,090 | 8,661 | 6,861 | 3,300 |
| Accrued Expenses | 21,621 | 18,480 | 14,159 | 6,704 | 10,059 |
| TOTAL | $38,733 | $30,926 | $27,890 | $19,170 | $19,735 |
| Non-Current Liabilities | |||||
| Long Term Debt | 50,000 | 50,000 | N/A | N/A | N/A |
| Deferred Revenues | 1,099 | N/A | N/A | N/A | N/A |
| TOTAL | $50,000 | $50,000 | $N/A | $N/A | $N/A |
| Total Liabilities | $88,733 | $80,926 | $27,890 | $19,170 | $19,735 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,575 | 39,188 | 39,051 | 36,658 | 36,232 |
| Common Shares | 394 | 391 | 390 | 363 | 361 |
| Retained earnings | -585,971 | -538,008 | -489,499 | -446,273 | -412,828 |
| Other shareholders' equity | -17 | -17 | -1 | 1 | -40 |
| TOTAL | $-21,251 | $17,880 | $57,841 | $92,676 | $118,110 |
| Total Liabilities And Equity | $67,482 | $98,806 | $85,731 | $111,846 | $137,845 |